Bio Path reported $5.16M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Alterity Therapeutics Limited AUD 1.07M 203.72K Dec/2025
Baxter International USD 1.02B 10M Sep/2026
Bio Path USD 5.16M 260K Mar/2026
Cipla INR 32.66B 361.1M Sep/2026
Clal Biotechnology ILS 21.05M 1.62M Dec/2021
Compugen USD 2.15M 371K Jun/2026
CSL USD 3.17B 290M Dec/2025
Grifols EUR 987.75M 47.87M Dec/2025
Karyopharm Therapeutics USD 4.28M 276K Mar/2026